December 5, 2011

Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.

November 22, 2011

Generic drug maker Par Pharmaceutical has promoted Thomas Haughey to president and Paul Campanelli to COO, the company said. The promotions take effect immediately.

November 18, 2011

Par Pharmaceutical has completed its acquisition of Anchen Pharmaceuticals, the generic drug maker said.

September 12, 2011

The Generic Pharmaceutical Association has named Ralph Neas as its new president and CEO.

August 24, 2011

Par Pharmaceutical Cos. will acquire Anchen Pharmaceuticals for $410 million, Par said Wednesday.

August 3, 2011

Par Pharmaceutical had sales of $224.2 million and profits of $9.05 million during second quarter 2011, the drug maker said Wednesday.

July 5, 2011

As part of a strategic assessment, generic drug maker Par Pharmaceutical is set to restructure its branded division.

April 4, 2011

PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.

January 4, 2011

Par Pharmaceutical has started shipping a generic version of a hypertension drug, the company said Monday.

January 4, 2011

Generic drug maker Par Pharmaceutical has begun shipping its version of a treatment for heart rhythm problems, the company said Monday.

December 20, 2010

The president of Par Pharmaceutical's subsidiary announced his resignation on Monday.

November 22, 2010

WOODCLIFF LAKE, N.J. Par Pharmaceutical has begun shipments of a generic treatment for asthma, the drug maker said Monday.

Par announced that it started shipping zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a generic version of AstraZeneca’s Accolate.

Accolate has sales of $50 million in the United States per year, according to IMS Health.

November 14, 2010

The world of generic drugs has a big year ahead of it. Actually, it has...

October 4, 2010

The Food and Drug Administration has approved a generic treatment for cough and upper respiratory...

July 22, 2010

Generic drug maker Par Pharmaceutical Cos. has appointed a former Roche executive to its board...

July 12, 2010

Generic drug maker Amneal Pharmaceuticals has appointed a former Par Pharmaceutical Cos. executive as chief...

June 30, 2010

Generic drug maker Par Pharmaceutical has launched a generic version of a drug used to...

June 3, 2010

Par Pharmaceutical's CFO and EVP Lawrence Kenyon has resigned, the generic drug maker said Friday....

January 11, 2009

Par Pharmaceutical Cos. had total sales of $291.9 million and $26.3 million in profit for...